IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

Growth Control and Cancer Metastasis News

Institutional
”la Caixa” Foundation backs research into breast and colon cancer at IRB Barcelona
Institutional
ADAPTMET: A new era in cancer metastasis research
Media mentions
Qué fue de los alumnos 10 de Selectividad de hace una década - El País
Innovation
Inbiomotion and Source BioScience sign an exclusive agreement for MAF Test® in United Kingdom and Ireland
Institutional
World Cancer Day 2024: Highlights of IRB Barcelona’s cancer research
Diogo Soares and Miloš Lazić, PhD students at IRB Barcelona.
Community
Empowering Tomorrow's Leaders in Metastasis Research
Innovation
Inbiomotion and The Scientific Group sign an exclusive distribution agreement of MAF Test® for the Sub-Saharan Africa
Scientific
Researchers decipher the mechanism by which the MAF protein promotes breast cancer metastasis
Media mentions
La revolta de les teràpies dirigides contra el càncer - ARA
Media mentions
Ja ens operen robots. Com seran els metges del futur? - TV3
Institutional
The IRB Barcelona spin-off Inbiomotion validates its test, which will help reduce mortality in breast cancer
Media mentions
Inbiomotion valida su test de cáncer de mama con un potencial de 1.000 millones - Expansión
Institutional
1st Evomet Annual Meeting sets the scene for an ambitious project: ensuring the next generation of leaders in metastasis research
Innovation
The MAF test® for patients with breast cancer gets closer to the market
Dr. Roger Gomis (IRB Barcelona researcher, Inbiomotion Founder and CSO) and Dr. Joël Jean-Mairet (Inbiomotion Executive Chaiman)
Innovation
IRB Barcelona spin-off Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival
Innovation
Alta Life Sciences leads an oversubscribed investment round into Inbiomotion to launch its diagnostic product in breast cancer
Institutional
IRB Barcelona to coordinate the European Project Evomet, which will train future leaders in metastasis research
Roger Gomis, head of the Growth Control and Metastasis Lab at IRB Barcelona
Media mentions
World Cancer Day
Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.
Media mentions
The most common breast cancer under siege
Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.
Institutional
Researcher Roger Gomis receives a grant from the Fundación Fero to study metastatic breast cancer
Photos of the presentation ceremony of the awards given by the Fundació La Marató
Institutional
La Marató awards six projects that involve IRB Barcelona
Community
When patients and scientists join forces: a story of hope
Different localization of the proteins involved in apoptosis in basal (Ctrl) and upon death receptor induction with TRAIL. Saška Ivanova, IRB Barcelona
Scientific
Researchers identify a new biomarker for personalised treatments against cancer
Press conference at IRB Barcelona, presenting the #MetastasisChallenge
Media mentions
IRB Barcelona wants to raise €5 M for research into metastasis
Press conference at IRB Barcelona, presenting the #MetastasisChallenge
Institutional
IRB Barcelona calls society to action in the fight against metastasis
100tífiques. Source: FCRI
Outreach
Gathering of “100tífiques”: fostering education to change stereotypes that drive girls away from science
Roger Gomis, head of the Growth Control and Cancer Metastasis Lab
Media mentions
More research has to be done into cancer
Biennal Ciutat i Ciència
Outreach
IRB Barcelona to participate in the first Biennal Ciutat i Ciència event
Roger Gomis, head of the Growth Control and Cancer Metastasis Lab
Media mentions
Old drugs to stop breast cancer metastasis
Roger Gomis, head of the Growth Control and Cancer Metastasis Lab
Media mentions
A new weapon in the fight against metastasis